Literature DB >> 10917521

The 3.2-A crystal structure of the human IgG1 Fc fragment-Fc gammaRIII complex.

P Sondermann1, R Huber, V Oosthuizen, U Jacob.   

Abstract

The immune response depends on the binding of opsonized antigens to cellular Fc receptors and the subsequent initiation of various cellular effector functions of the immune system. Here we describe the crystal structures of a soluble Fc gamma receptor (sFc gammaRIII, CD16), an Fc fragment from human IgG1 (hFc1) and their complex. In the 1:1 complex the receptor binds to the two halves of the Fc fragment in contact with residues of the C gamma2 domains and the hinge region. Upon complex formation the angle between the two sFc gammaRIII domains increases significantly and the Fc fragment opens asymmetrically. The high degree of amino acid conservation between sFc gammaRIII and other Fc receptors, and similarly between hFc1 and related immunoglobulins, suggest similar structures and modes of association. Thus the described structure is a model for immune complex recognition and helps to explain the vastly differing affinities of other Fc gammaR-IgG complexes and the Fc epsilonRI alpha-IgE complex.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10917521     DOI: 10.1038/35018508

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  242 in total

1.  The principle of delivery of T cell epitopes to antigen-presenting cells applied to peptides from influenza virus, ovalbumin, and hen egg lysozyme: implications for peptide vaccination.

Authors:  I B Rasmussen; E Lunde; T E Michaelsen; B Bogen; I Sandlie
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-21       Impact factor: 11.205

Review 2.  Transcytosis and catabolism of antibody.

Authors:  Victor Ghetie; E Sally Ward
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

Review 3.  Diversity and duplicity: human FCgamma receptors in host defense and autoimmunity.

Authors:  Robert P Kimberly; Jianming Wu; Andrew W Gibson; Kaihong Su; Hongwe Qin; Xiaoli Li; Jeffrey C Edberg
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

Review 4.  Advances in the understanding of the Fc gamma receptors-mediated autoantibodies uptake.

Authors:  Sabrina Lisi; Margherita Sisto; Dario Domenico Lofrumento; Simona D'Amore; Massimo D'Amore
Journal:  Clin Exp Med       Date:  2010-05-09       Impact factor: 3.984

5.  The Fc Domain of Immunoglobulin Is Sufficient to Bridge NK Cells with Virally Infected Cells.

Authors:  Hong-Sheng Dai; Nathaniel Griffin; Chelsea Bolyard; Hsiaoyin Charlene Mao; Jianying Zhang; Timothy P Cripe; Tadahiro Suenaga; Hisashi Arase; Ichiro Nakano; E A Chiocca; Balveen Kaur; Jianhua Yu; Michael A Caligiuri
Journal:  Immunity       Date:  2017-07-18       Impact factor: 31.745

Review 6.  Fc receptors and their role in immune regulation and autoimmunity.

Authors:  Toshiyuki Takai
Journal:  J Clin Immunol       Date:  2005-01       Impact factor: 8.317

7.  Impact of Glycosylation on the Local Backbone Flexibility of Well-Defined IgG1-Fc Glycoforms Using Hydrogen Exchange-Mass Spectrometry.

Authors:  Apurva S More; Ronald T Toth; Solomon Z Okbazghi; C Russell Middaugh; Sangeeta B Joshi; Thomas J Tolbert; David B Volkin; David D Weis
Journal:  J Pharm Sci       Date:  2018-05-08       Impact factor: 3.534

8.  Structure of the streptococcal endopeptidase IdeS, a cysteine proteinase with strict specificity for IgG.

Authors:  Katja Wenig; Lorenz Chatwell; Ulrich von Pawel-Rammingen; Lars Björck; Robert Huber; Peter Sondermann
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-01       Impact factor: 11.205

9.  Identification and expression of human cytomegalovirus transcription units coding for two distinct Fcgamma receptor homologs.

Authors:  Ramazan Atalay; Albert Zimmermann; Markus Wagner; Eva Borst; Christine Benz; Martin Messerle; Hartmut Hengel
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

10.  Immunoglobulin G1 Fc domain motions: implications for Fc engineering.

Authors:  Martin Frank; Ross C Walker; William N Lanzilotta; James H Prestegard; Adam W Barb
Journal:  J Mol Biol       Date:  2014-02-09       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.